TransBiotec Inc (OTC Pink - No Information:IMLE)

0.006
Delayed Data
As of Jun 12
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
0.02
+76.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization777.00776.00454.000.00
 
 
 
 
 
Operating ExpensesGross Income-777.00-776.00-454.000.00
 
 
 
 
General Expenses783.8K505.6K447.0K396.1K
 
 
 
 
 
Total Operating Expenses784.6K506.3K447.4K396.1K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-784.6K-506.3K-447.4K-396.1K
 
 
 
 
 
Extraordinary Credit286.0K0.0025.9K0.00
 
 
 
Extraordinary Charge0.00-21.6K0.000.00
 
 
Interest Expense On Debt264.6K221.0K275.3K203.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-763.2K-748.9K-696.7K-599.2K
 
 
 
 
 
Minority Interest-4.8K-4.4K-5.0K-4.1K
 
 
 
 
 
Net Income-758.4K-744.6K-691.7K-595.1K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.5M39.2M59.3M67.3M
 
 
 
 
 
Shares To Calculate EPS Diluted32.5M39.2M59.3M67.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.01-$0.01
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.01-$0.01